Advertisement

Diagnostic Tools: Cardiac MRI for Structural Heart Disease and Catheter-Based Cardiovascular Interventions

  • Frank E. CorriganIII
  • Kweku Appau
  • Stamatios Lerakis
Chapter

Abstract

Cardiovascular magnetic resonance imaging has enhanced noninvasive evaluation and management of patients with several forms of cardiovascular disease. The role is increasing due to its improved soft tissue contrast, capacity to perform multiplanar reconstructions, and ability to visualize and quantify cardiac function without the use of ionizing radiation. Phase contrast imaging allows for velocity and flow assessment, as well as gradient estimation, providing important diagnostic information for structural and valvular disorders. Catheter-based interventions under magnetic resonance rather than fluoroscopic guidance are currently under investigation. As percutaneous cardiovascular intervention becomes more complex, the need for enhanced soft tissue visualization without ionizing radiation will allow for the expansion of magnetic resonance–guided intervention.

Notes

Acknowledgments

The authors would like to give special appreciation to Dr. Robert Lederman and his team at the National Heart, Lung, and Blood Institute, National Institutes of Health, for their work and instructional assistance in real-time MRI guidance for catheter-based intervention.

References

  1. 1.
    Lopez-Mattei JC, Shah DJ. The role of cardiac magnetic resonance in valvular heart disease. Methodist Debakey Cardiovasc J. 2013;9(3):142–8.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J. 2000;21(16):1387–96.CrossRefPubMedGoogle Scholar
  3. 3.
    Nayak KS, Nielsen JF, Bernstein MA, Markl M, Gatehouse PD, Botnar MR, et al. Cardiovascular magnetic resonance phase contrast imaging. J Cardiovasc Magn Reson. 2015;17:71.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2000;2(4):271–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Marwick TH, Neubauer S, Petersen SE. Use of cardiac magnetic resonance and echocardiography in population-based studies: why, where, and when? Circ Cardiovasc Imaging. 2013;6(4):590–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Cavalcante JL, Lalude OO, Schoenhagen P, Lerakis S. Cardiovascular magnetic resonance imaging for structural and valvular heart disease interventions. JACC Cardiovasc Interv. 2016;9(5):399–425.CrossRefPubMedGoogle Scholar
  7. 7.
    Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation. 2009;119(3):468–78.CrossRefPubMedGoogle Scholar
  8. 8.
    Masci PG, Dymarkowski S, Bogaert J. Valvular heart disease: what does cardiovascular MRI add? Eur Radiol. 2008;18(2):197–208.CrossRefPubMedGoogle Scholar
  9. 9.
    Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, et al. ESC Working Group on Valvular Heart Disease position paper—heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013;34(21):1597–606.CrossRefPubMedGoogle Scholar
  10. 10.
    American College of Cardiology Foundation Task Force on Expert, Consensus D, Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation. 2010;121(22):2462–508.CrossRefGoogle Scholar
  11. 11.
    Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58(12):1271–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Mavrogeni S, Markousis-Mavrogenis G, Markussis V, Kolovou G. The emerging role of cardiovascular magnetic resonance imaging in the evaluation of metabolic cardiomyopathies. Horm Metab Res. 2015;47(9):623–32.CrossRefPubMedGoogle Scholar
  13. 13.
    Wassmuth R, von Knobelsdorff-Brenkenhoff F, Gruettner H, Utz W, Schulz-Menger J. Cardiac magnetic resonance imaging of congenital bicuspid aortic valves and associated aortic pathologies in adults. Eur Heart J Cardiovasc Imaging. 2014;15(6):673–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Park J, Chang HJ, Choi JH, Yang PS, Lee SE, Heo R, et al. Late gadolinium enhancement in cardiac MRI in patients with severe aortic stenosis and preserved left ventricular systolic function is related to attenuated improvement of left ventricular geometry and filling pressure after aortic valve replacement. Korean Circ J. 2014;44(5):312–9.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Hartlage GR, Babaliaros VC, Thourani VH, Hayek S, Chrysohoou C, Ghasemzadeh N, et al. The role of cardiovascular magnetic resonance in stratifying paravalvular leak severity after transcatheter aortic valve replacement: an observational outcome study. J Cardiovasc Magn Reson. 2014;16:93.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Myerson SG, d'Arcy J, Mohiaddin R, Greenwood JP, Karamitsos TD, Francis JM, et al. Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation. 2012;126(12):1452–60.CrossRefPubMedGoogle Scholar
  17. 17.
    Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:7.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):e521–643.CrossRefPubMedGoogle Scholar
  19. 19.
    Han Y, Peters DC, Salton CJ, Bzymek D, Nezafat R, Goddu B, et al. Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging. 2008;1(3):294–303.CrossRefPubMedGoogle Scholar
  20. 20.
    Steinmetz M, Preuss HC, Lotz J. Non-invasive imaging for congenital heart disease—recent progress in cardiac MRI. J Clin Exper Cardiol. 2012;15:2012.Google Scholar
  21. 21.
    Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk AP, Spijkerboer AM, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007;116(5):545–51.CrossRefPubMedGoogle Scholar
  22. 22.
    Kilner PJ. The role of cardiovascular magnetic resonance in adults with congenital heart disease. Prog Cardiovasc Dis. 2011;54(3):295–304.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Teo KS, Disney PJ, Dundon BK, Worthley MI, Brown MA, Sanders P, et al. Assessment of atrial septal defects in adults comparing cardiovascular magnetic resonance with transoesophageal echocardiography. J Cardiovasc Magn Reson. 2010;12:44.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults with Congenital Heart Disease). Circulation. 2008;118(23):2395–451.CrossRefPubMedGoogle Scholar
  25. 25.
    de la Pena E, Nguyen PK, Nayak KS, Yang PC, Rosenthal DN, Hu BS, et al. Real-time color-flow CMR in adults with congenital heart disease. J Cardiovasc Magn Reson. 2006;8(6):809–15.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Clarke JR, Strohm O, Patton DJ. Patent ductus arteriosus demonstrated in an adult patient using cardiovascular magnetic resonance imaging. Can J Cardiol. 2009;25(1):e17.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Muzzarelli S, Meadows AK, Ordovas KG, Higgins CB, Meadows JJ. Usefulness of cardiovascular magnetic resonance imaging to predict the need for intervention in patients with coarctation of the aorta. Am J Cardiol. 2012;109(6):861–5.CrossRefPubMedGoogle Scholar
  28. 28.
    Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31(23):2915–57.CrossRefPubMedGoogle Scholar
  29. 29.
    Jahnke C, Hindricks G, Sommer P, Paetsch I. Cardiovascular magnetic resonance imaging for the detection and follow-up of isolated partial anomalous pulmonary venous connection. Eur Heart J. 2015;36(34):2337.CrossRefPubMedGoogle Scholar
  30. 30.
    Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9(4):632–96. e21CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Kramer CM, Narula J. Interventional CMR: great promise, but a long road ahead. JACC Cardiovasc Imaging. 2009;2(11):1337–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Saikus CE, Lederman RJ. Interventional cardiovascular magnetic resonance imaging: a new opportunity for image-guided interventions. JACC Cardiovasc Imaging. 2009;2(11):1321–31.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Rogers T, Lederman RJ. Interventional CMR: clinical applications and future directions. Curr Cardiol Rep. 2015;17(5):31.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Ratnayaka K, Faranesh AZ, Guttman MA, Kocaturk O, Saikus CE, Lederman RJ. Interventional cardiovascular magnetic resonance: still tantalizing. J Cardiovasc Magn Reson. 2008;10:62.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Barbash IM, Saikus CE, Faranesh AZ, Ratnayaka K, Kocaturk O, Chen MY, et al. Direct percutaneous left ventricular access and port closure: pre-clinical feasibility. JACC Cardiovasc Interv. 2011;4(12):1318–25.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Ratnayaka K, Saikus CE, Faranesh AZ, Bell JA, Barbash IM, Kocaturk O, et al. Closed-chest transthoracic magnetic resonance imaging-guided ventricular septal defect closure in swine. JACC Cardiovasc Interv. 2011;4(12):1326–34.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Halabi M, Ratnayaka K, Faranesh AZ, Hansen MS, Barbash IM, Eckhaus MA, et al. Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility. J Cardiovasc Magn Reson. 2013;15:10.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Ganesan AN, Selvanayagam JB, Mahajan R, Grover S, Nayyar S, Brooks AG, et al. Mapping and ablation of the pulmonary veins and cavo-tricuspid isthmus with a magnetic resonance imaging-compatible externally irrigated ablation catheter and integrated electrophysiology system. Circ Arrhythm Electrophysiol. 2012;5(6):1136–42.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Frank E. CorriganIII
    • 1
  • Kweku Appau
    • 1
  • Stamatios Lerakis
    • 1
  1. 1.Emory University School of Medicine, Department of Radiology and Department of Medicine, Division of CardiologyEmory University HospitalAtlantaUSA

Personalised recommendations